STAT readers on reaching anti-vaxxers
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Jason Karlawish, who writes STAT’s Neurotransmissions ...
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Apparently, some vets are already ...
This is the online version of ASH in 30 Seconds, STAT’s report from the American Society of Hematology meeting. Sign ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
BANGOR — Steven Cronk, 41, sleeps among a row of tattered, sun-bleached tents that cling to a small strip of ...
WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
President Trump described his administration’s agreement with Pfizer on several drug pricing plans as a historic measure to lower costs ...
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.